Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle’s Eye View: Saturday, November 11 — Daily Wrap Up | AHA 2023

Nov 11, 2023
Experts review late-breaking clinical trials at AHA 2023, including semaglutide's benefits in obese patients with cardiovascular disease, the cardiometabolic effects of DAPA in acute MI patients, and the effectiveness of PCI vs. medical therapy in patients with angina.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 4min
2
Assessing the Cardiometabolic Effects of DAPA in Acute MI Patients
04:02 • 3min
3
Comparing PCI Effectiveness vs. Medical Therapy in Patients with Angina
07:28 • 4min